A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported.

from Latest Science News -- ScienceDaily http://ift.tt/1OmRZeO
via
Aucun commentaire:
Enregistrer un commentaire